This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Certain index funds offer superior tax efficiency due to turnover and structure; evaluate these factors when building your lineup.
25,966 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Archer Aviation faces a critical cash burn challenge as it works toward FAA certification and commercial revenues. Th...
A wave of at-home red light therapy devices is gaining traction as Americans weigh costs and potential skincare and r...
A widespread fraud targeted older Americans by posing as Publishers Clearing House winners. Federal investigators say...
Costco blends a lean merchandise line with a robust membership model to outpace rivals. The costco pricing secret tha...
Bitcoin faces a fresh test as five straight weeks of spot ETF withdrawals drain billions. Miners liquidate, bids thin...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
An in-depth look at Workhorse's path in 2026, focusing on earnings potential, drivers, and strategies for investors n...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Prescription drug costs can surprise even careful savers. This guide shares practical, real-world tactics to lower wh...
Warren Buffett is terminating his storied partnership with the Gates Foundation, directing billions to family-led fou...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...